粪便蛋白酶与免疫特征驱动IBS亚型特异性肠神经激活
研究比较21例腹泻型IBS、9例便秘型IBS和18例健康对照的粪便上清对豚鼠远端结肠黏膜下神经丛神经元的影响,发现IBS-D和IBS-C均显著激活神经元,但IBS-D由丝氨酸/半胱氨酸蛋白酶及PAR-1介导且粪便蛋白组富集免疫成分,IBS-C则不依赖这些因素。
要点
- IBS-D和IBS-C粪便上清均直接激活肠神经元,但机制不同。
- IBS-D的神经元激活依赖丝氨酸/半胱氨酸蛋白酶及PAR-1。
- IBS-D粪便蛋白组有47种蛋白差异,含免疫球蛋白成分。
核心结论
- IBS存在腔-肠神经轴,IBS-D与IBS-C病理机制根本不同:IBS-D由蛋白酶和PAR-1依赖的神经元激活及免疫富集蛋白组驱动,IBS-C不依赖这些因素。
研究设计与样本
- 多国多中心研究:纳入21例IBS-D、9例IBS-C和18例健康对照,用神经影像技术评估粪便上清对豚鼠远端结肠黏膜下神经丛神经元的作用,并分析粪便蛋白水解活性和蛋白组。
主要发现
- IBS-D和IBS-C粪便上清诱发的神经元激活显著强于健康对照。
- IBS-D中该效应由丝氨酸和半胱氨酸蛋白酶及PAR-1介导,IBS-C中不由这些因子介导。
- IBS-D与健康对照之间有47种蛋白显著差异,包括多种免疫球蛋白成分。
- 淀粉酶、胰蛋白酶-2和一种免疫球蛋白蛋白联合可高诊断性能区分IBS-D与健康对照。
临床怎么用
- 提示粪便蛋白酶活性和蛋白组标志物可用于IBS亚型鉴别诊断。
- IBS-D可考虑靶向蛋白酶/PAR-1通路及免疫微炎症的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Luminal proteases have been implicated in epithelial barrier dysfunction and visceral hypersensitivity in irritable bowel syndrome (IBS), yet their impact on the enteric nervous system (ENS), the principal regulator of gastrointestinal function, remains unknown. OBJECTIVE: To investigate whether faecal mediators differentially activate enteric neurons across IBS subtypes and whether proteolytic and proteomic profiles explain neuronal phenotypes. DESIGN: The effects of faecal supernatants (FSN) from 21 IBS-D (diarrhoea-predominant), 9 IBS-C (constipation-predominant) and 18 healthy control (HC) patients recruited across centres in three countries on guinea pig distal colon submucous plexus neurons were assessed using a neuroimaging technique. Faecal proteolytic activities and proteomic profiles were analysed. RESULTS: IBS-D and IBS-C supernatants evoked significantly stronger neuronal activation than HC, demonstrating that FSN directly modulate ENS. In IBS-D, but not IBS-C, effects were mediated by serine and cysteine proteases and PAR-1. Proteome analysis revealed a significant difference in 47 proteins between IBS-D and HC, including several immunoglobulin components, underlying the role of microinflammation in IBS-D. A combination of amylases, trypsin-2 and an immunoglobulin protein demonstrated high diagnostic performance to distinguish IBS-D from HC. CONCLUSION: These findings uncover a previously unrecognised luminal-ENS axis in IBS and reveal fundamentally different pathological mechanisms between IBS-D and IBS-C. IBS-D is characterised by proteases and PAR-1-dependent neuronal activation and a distinct immune-enriched faecal proteome, whereas mediators in IBS-C act independently of these factors. These findings establish a functional link between faecal protease activity, ENS signalling and molecular biomarkers, highlighting new therapeutic and diagnostic avenues for subtype-specific management of IBS.
引用
- Ridžal L, Frieling T, Róka R, et al. Faecal proteases and immune signatures drive subtype-specific enteric neuronal activation in IBS. Gut. 2026. PMID: 42552107. doi:10.1136/gutjnl-2025-337949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。